Progress of autologous hematopoietic stem cell transplantation for malignant lymphoma treatment / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 765-768, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-664151
ABSTRACT
Autologous hematopoietic stem cell transplantation (AHSCT) is an important method for treatment of malignant lymphoma. Its treatment process is relatively complex, and the curative effect can be affected by many factors. AHSCT has been widely applied in different subtypes of ML treatment, and looking for effective prognostic factors to further differentiate patients who may benefit from AHSCT and formulating reasonable transplantation are important issues for the clinical doctors to deal with. This article briefly reviews the clinical progress of AHSCT for ML treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS